-+ 0.00%
-+ 0.00%
-+ 0.00%

CADRENAL THERAPEUTICS - PHASE 3 TRIAL TO ASSESS BLEEDING AS MAJOR SAFETY ENDPOINT USING ISTH CRITERIA

Reuters·08/31/2026 12:00:02

Please log in to view news